These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30256712)

  • 21. Comparative financing analysis and political economy of noncommunicable diseases.
    Jakovljevic M; Jakab M; Gerdtham U; McDaid D; Ogura S; Varavikova E; Merrick J; Adany R; Okunade A; Getzen TE
    J Med Econ; 2019 Aug; 22(8):722-727. PubMed ID: 30913928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How much donor financing for health is channelled to global versus country-specific aid functions?
    Schäferhoff M; Fewer S; Kraus J; Richter E; Summers LH; Sundewall J; Yamey G; Jamison DT
    Lancet; 2015 Dec; 386(10011):2436-41. PubMed ID: 26178405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender-Based Approaches for the Prevention and Control of Noncommunicable Diseases.
    Baschieri F; Acciarresi M; Caso V
    Stroke; 2018 Dec; 49(12):2810-2811. PubMed ID: 30571452
    [No Abstract]   [Full Text] [Related]  

  • 24. Development Assistance for Health: Potential Contribution to the Post-2015 Agenda.
    Haines A
    JAMA; 2015 Jun; 313(23):2328-30. PubMed ID: 26080337
    [No Abstract]   [Full Text] [Related]  

  • 25. Noncommunicable Disease Risk Factors in Developing Countries: Policy Perspectives.
    Kostova D; Chaloupka FJ; Frieden TR; Henning K; Paul J; Osewe PL; Asma S
    Prev Med; 2017 Dec; 105S():S1-S3. PubMed ID: 28988998
    [No Abstract]   [Full Text] [Related]  

  • 26. Health Aid Is Allocated Efficiently, But Not Optimally: Insights From A Review Of Cost-Effectiveness Studies.
    Bendavid E; Duong A; Sagan C; Raikes G
    Health Aff (Millwood); 2015 Jul; 34(7):1188-95. PubMed ID: 26153314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Building on the HIV platform: tackling the challenge of noncommunicable diseases among persons living with HIV.
    El-Sadr WM; Goosby E
    AIDS; 2018 Jul; 32 Suppl 1():S1-S3. PubMed ID: 29952785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global Health diplomacy for noncommunicable diseases prevention and control: a systematic review.
    Afshari M; Ahmadi Teymourlouy A; Asadi-Lari M; Maleki M
    Global Health; 2020 May; 16(1):41. PubMed ID: 32375804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing US Global Health Funding.
    Parekh A
    JAMA; 2023 May; 329(17):1447-1448. PubMed ID: 36995694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obligations of low income countries in ensuring equity in global health financing.
    Barugahare J; Lie RK
    BMC Med Ethics; 2015 Sep; 16():59. PubMed ID: 26351245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [International financing for cooperation to develop health in Latin America and the Caribbean].
    De Los Ríos R; Arósquipa C; Vigil-Oliver W
    Rev Panam Salud Publica; 2011 Aug; 30(2):133-43. PubMed ID: 22159722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sector-wide or disease-specific? Implications of trends in development assistance for health for the SDG era.
    Buffardi AL
    Health Policy Plan; 2018 Apr; 33(3):381-391. PubMed ID: 29351607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Bangkok Declaration on Physical Activity for Global Health and Sustainable Development.
    ISPAH International Society for Physical Activity and Health
    Br J Sports Med; 2017 Oct; 51(19):1389-1391. PubMed ID: 28642224
    [No Abstract]   [Full Text] [Related]  

  • 34. Evolution and patterns of global health financing 1995-2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2017 May; 389(10083):1981-2004. PubMed ID: 28433256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergies between Communicable and Noncommunicable Disease Programs to Enhance Global Health Security.
    Kostova D; Husain MJ; Sugerman D; Hong Y; Saraiya M; Keltz J; Asma S
    Emerg Infect Dis; 2017 Dec; 23(13):S40-6. PubMed ID: 29155655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Avoiding a legacy of unequal non-communicable disease burden after the COVID-19 pandemic.
    Maani N; Abdalla SM; Galea S
    Lancet Diabetes Endocrinol; 2021 Mar; 9(3):133-135. PubMed ID: 33549161
    [No Abstract]   [Full Text] [Related]  

  • 37. Development assistance for health: past trends, associations, and the future of international financial flows for health.
    Dieleman JL; Schneider MT; Haakenstad A; Singh L; Sadat N; Birger M; Reynolds A; Templin T; Hamavid H; Chapin A; Murray CJ
    Lancet; 2016 Jun; 387(10037):2536-44. PubMed ID: 27086170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes and NCD research: meeting the needs of the patient.
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):873. PubMed ID: 27793312
    [No Abstract]   [Full Text] [Related]  

  • 39. HIV and NCDs: the need to build stronger health systems.
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):549-50. PubMed ID: 27290621
    [No Abstract]   [Full Text] [Related]  

  • 40. Overcoming internal challenges and external threats to noncommunicable disease control.
    Tangcharoensathien V; Chandrasiri O; Waleewong O; Rajatanavin N
    Bull World Health Organ; 2019 Feb; 97(2):74-74A. PubMed ID: 30728609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.